ST. LOUIS — OpenCell Technologies, an R&D-stage biomedical venture, has announced the hiring of Kevin Gutshall as CEO. Kevin leaves his role as MilliporeSigma’s director of life science business development and M&A focusing on the cell and gene therapy business unit, to join OpenCell and lead its efforts to translate and commercialize its core technology platform, POROS. OpenCell was […]
MENLO PARK, Calif. — IONpath, Inc., the leader in multiplexed spatial tissue imaging and analysis, today announced the appointment of Brad Nelson to the position of Senior Vice President of Marketing and Corporate Strategy. Mr. Nelson will lead marketing, product management and application functions to meet the increasing demand for translational medicine insights that can […]
The appointment will support a strategic expansion into large-scale proteomics applications across the drug development value chain. (Schlieren (Zurich) Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announces today the appointment of Dr. Patrick Vink as Chairman of the Board of Directors. Dr. Vink replaces Mr. Harry Welten, who joined the Biognosys […]
WALTHAM, Mass. — Repligen Corporation (NASDAQ:RGEN) today announced the appointment of healthcare industry executive Carrie Eglinton Manner to its Board of Directors. Ms. Eglinton Manner brings to the director role over 23 years of leadership experience across multiple disciplines. She currently serves as Senior Vice President, Advanced Diagnostics at Quest Diagnostics (NYSE:DGX), the world’s leading […]
Dr. Hunkapiller to retire by the end of 2020 Susan K. Barnes, CFO to retire in August 2020 MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that Michael Hunkapiller, Ph.D. is retiring as Chief Executive Officer and President by the end […]
— Hesperos participating in panel session and presenting company overview at the BIO International Convention (BIO Digital) — Hesperos Inc., pioneers of the Human-on-a-Chip® in vitro system, today announced the appointment of Gilberto M. (Ybet) Villacorta, Ph.D., J.D., as Executive Vice President for Business Development. He was previously Hesperos’ Corporate Secretary. Bringing decades of corporate […]
KIEL, Germany — Effective today, Cellbox Solutions GmbH announces the appointment of former Head of Biosolutions R&D from Lonza Pharma and Biotech, Dr. Herbert A. Mueller-Hartmann, as the new Head of Research and Development. Dr. Mueller-Hartmann will be continuing on the successful work of Dr. Hans-Otto Nagels. Wolfgang Kintzel, CEO of Cellbox Solutions, commented: “As Cellbox Solutions enters into its […]
Axel Jaeger becomes new Chief Financial Officer of Eppendorf AG Hamburg – The Supervisory Board of Eppendorf AG has appointed Axel Jaeger as the company’s new Chief Financial Officer (CFO). The 53-year-old financial expert will take over the management of the Hamburg-based life science company’s Finance, IT and Controlling division on June 1, 2020. He succeeds Detmar […]
GE Healthcare Commercial Executive brings a breadth of experience in scientific instrumentation and global markets to drive North American presence Borehamwood, UK: H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety and scale-up, today announced the appointment of Mert Sahin Ph.D. as General Manager and Senior Vice President of […]
STATESVILLE, N.C. June 1, 2020 /PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that Douglas J. Batdorff has joined the Company as Vice President of Manufacturing Operations. Mr. Batdorff will have responsibility for all of Kewaunee’s domestic manufacturing operations. Mr. Batdorff has a Bachelor of Science in Mechanical Engineering from Michigan State University and […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
